IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
According to IM Cannabis Corp.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.65. At the end of 2022 the company had a P/E ratio of -2.28.
Year | P/E ratio |
---|---|
2023 | -3.65 |
2022 | -2.28 |
2021 | -6.27 |
2020 | -80.12 |
2019 | -0.56 |
2018 | 2.24 |
2017 | -0.55 |
2016 | -4.49 |
2015 | -1.42 |
2014 | -54.61 |
2013 | -1.00 |
2012 | -0.77 |
2011 | -14.09 |
2010 | -31.85 |
2009 | -12.31 |
2008 | -11.82 |
2007 | -11.98 |
2006 | -12.26 |
2005 | -2.67 |
2004 | -379.16 |
2003 | -5.39 |
2002 | -4.48 |
2001 | -6.08 |
2000 | -4.28 |
1999 | -12.33 |
1998 | -1.85 |
1997 | -3.58 |
1996 | -16.46 |